Granules India advanced 1.59% to Rs 426.90 after the company announced that the US Food & Drug Administration (US FDA) has approved its abbreviated new drug application (ANDA) for Colchicine Capsules.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
